A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
about
Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.The Conventional Nature of Non-MHC-Restricted T Cells.Improving Immunotherapy Through Glycodesign
P2860
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase I vaccination study wi ...... n high-risk melanoma patients.
@en
A phase I vaccination study wi ...... n high-risk melanoma patients.
@nl
type
label
A phase I vaccination study wi ...... n high-risk melanoma patients.
@en
A phase I vaccination study wi ...... n high-risk melanoma patients.
@nl
prefLabel
A phase I vaccination study wi ...... n high-risk melanoma patients.
@en
A phase I vaccination study wi ...... n high-risk melanoma patients.
@nl
P2093
P2860
P50
P1476
A phase I vaccination study wi ...... n high-risk melanoma patients.
@en
P2093
Brigitta Mester
Catherine Barrow
Catherine E Wood
Colin M Hayman
Evelyn Bauer
Gavin F Painter
Geoffrey M Williams
Graham Caygill
Jeremy Jones
Jerome Macapagal
P2860
P2888
P304
P356
10.1007/S00262-017-2085-9
P577
2017-11-01T00:00:00Z